Avidity Biosciences CFO Sells $3.7M in Stock Amid Positive News by Terry Bingman 15.06.2024 Avidity Biosciences sees share ownership shift as MacLean reduces holding under Rule 10b5-1 Plan; positive sector developments bolster outlook.
NRx Pharmaceuticals: $5M Boost for NRX-101 Drug by Mark Eisenberg 12.02.2024 NRx Pharmaceuticals receives a $5 million milestone payment for the development of its drug candidate NRX-101, supporting its progress through ...
FDA Approves Takeda’s EoE Therapy EOHILIA by Lilu Anderson 12.02.2024 FDA approves Takeda's EOHILIA as first-line treatment for Eosinophilic Esophagitis. Groundbreaking oral therapy offers hope for improved quality of life.